KineMed is a biotechnology company that specializes in providing translational and personalized medicine. The company offers unparalleled insight into the complex biological processes underlying the root causes of disease. It uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. It was founded in 2001 and headquartered in Emeryville, California.

Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy.

Nova Molecular, Inc., a subsidiary of SignalEnergy, Inc., is a Canadian company located in Montréal, QC, that develops pharmaceutical products.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX.

Novartis International Pharmaceutical Ltd. manufactures and distributes pharmaceutical products. The company is headquartered in Ireland.

Their technology has a proven track record since January 2010. ISS engages as a partner to aid their customers in managing their portfolios using their proprietary platform. They deliver unprecedented results with speed and efficiency enabling variances less than 10% from forecasts. Multiple deployment options customized for their customers.

Wuhan YZY Medical Science & Technology Co., Ltd. is a company headquartered in Wuhan, China, that manufactures medical treatment devices. The firm was founded in 2011. Xiao Gang Liu is the current CEO of the company.

Asahi Kasei Chemicals Corp. manufactures organic and industrial chemicals. It provides coating materials, latexes, pharmaceutical and food additives, explosives, photopolymers and platemaking systems, separation and ion-exchange membranes, cling film, storage bags, plastic film, sheet, and foam. The company is headquartered in Tokyo, Japan.

Medic, Inc. is a private company headquartered in the United States. The firm provides domain purchase and hosting services.

HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication. HealthBeacon also alerts patients when they need to take their medication and sends them a text when they forget.

Winkk, Inc. operates as a printed circuitry graphic layout company. The company is headquartered in Menlo Park, CA.

MSDx is a personalized medicine company developing blood testing products for brain diseases and is dedicated to providing the healthcare providers and patients with critical data that can be useful in diagnosis, monitoring, and assessing therapeutics response.Brain damage is devastating! Millions of people are affected by brain disorders yet there is virtually no blood test available. Neurological diseases represent a particularly critical sector for biomarkers and blood tests, since the disease process often takes place well before symptoms appear. Cost effective, reliable, blood based biomarkers can aid in disease detection before excessive damage takes place. They call their patented blood test panel WINDOW INTO THE BRAIN™.

Hangzhou Shuyao Technology Co., Ltd., established on 2021-08-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;software development;Wholesale of computer software, hardware and auxiliary equipment;Network technology service;Internet of Things Technology Services;Data processing and storage support services;Information Technology Consulting Services;software sales;Information system integration service;Software outsourcing service;Network Equipment Sales;Artificial intelligence theory and algorithm software development;Artificial intelligence application software development;Artificial intelligence basic software development;Information system operation and maintenance services;Computer System Services;translation service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).